{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:16:03Z","timestamp":1783044963136,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024990","name":"National Yang Ming Chiao Tung University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-A49-049-MY3andNSTC 114-2623-E-A49-001-NU"],"award-info":[{"award-number":["NSTC 113-2314-B-A49-049-MY3andNSTC 114-2623-E-A49-001-NU"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-A49-049-MY3"],"award-info":[{"award-number":["NSTC 113-2314-B-A49-049-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2623-E-A49-001-NU"],"award-info":[{"award-number":["NSTC 114-2623-E-A49-001-NU"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.nucmedbio.2026.109636","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:28:16Z","timestamp":1779319696000},"page":"109636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative biological evaluation of [18F]fluciclovine, [18F]FBPA-Fr, and [18F]FET for boron neutron capture therapy: Preclinical validation and clinical feasibility"],"prefix":"10.1016","volume":"156-157","author":[{"given":"Ting-Yu","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2026.109636_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102371","article-title":"Recurrent\/metastatic squamous cell carcinoma of the head and neck: a big and intriguing challenge which may be resolved by integrated treatments combining locoregional and systemic therapies","volume":"13","author":"Ionna","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010047","article-title":"Recurrent glioblastoma: from molecular landscape to new treatment perspectives","volume":"13","author":"Birzu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2020.109105","article-title":"Using salvage Boron Neutron Capture Therapy (BNCT) for recurrent malignant brain tumors in Taiwan","volume":"160","author":"Lan","year":"2020","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0020","series-title":"Progress in neutron capture therapy for cancer","first-page":"243","article-title":"Complex formation of phenylboronic acid derivatives with aldopentoses and oligosaccharides","author":"Kinoshita","year":"1992"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0025","first-page":"302","article-title":"Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model","volume":"45","author":"Wang","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0030","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1016\/S0040-4020(02)00489-1","article-title":"A detailed examination of boronic acid\u2013diol complexation","volume":"58","author":"Springsteen","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0035","doi-asserted-by":"crossref","first-page":"20564","DOI":"10.1002\/cam4.6635","article-title":"Correlation between L-amino acid transporter 1 expression and 4-borono-2-18F-fluoro-phenylalanine accumulation in humans","volume":"12","author":"Kashihara","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/cas.12602","article-title":"Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2","volume":"106","author":"Wongthai","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0045","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1021\/acs.molpharmaceut.3c01215","article-title":"Radiosynthesis and preclinical evaluation of m-[18F]FET and [18F]FET-OMe as novel [18F]FET analogs for brain tumor imaging","volume":"21","author":"Groner","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noae078","article-title":"PET imaging of gliomas: status quo and quo vadis?","volume":"26","author":"Galldiks","year":"2024","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13550-025-01279-7","article-title":"Kinetics of the amino acid uptake tracer O-(2-[18F]fluoroethyl)-L-tyrosine (FET) in human brain","volume":"15","author":"Krieger","year":"2025","journal-title":"EJNMMI Res"},{"issue":"Supplement 1","key":"10.1016\/j.nucmedbio.2026.109636_bb0060","article-title":"Role of 18F-fluciclovine PET\/ CT","volume":"66","author":"Obala","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.829050","article-title":"Imaging glioblastoma with 18F-fluciclovine amino acid positron emission tomography","volume":"12","author":"Scarpelli","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0070","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.7150\/thno.19883","article-title":"PET tracer 18F-fluciclovine can detect histologically proven bone metastatic lesions: a preclinical study in rat osteolytic and osteoblastic bone metastasis models","volume":"7","author":"Oka","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nucmedbio.2022.108313","article-title":"Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA)","volume":"116-117","author":"Chang","year":"2023","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0080","first-page":"1161","article-title":"Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer","volume":"47","author":"Wang","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0085","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.21037\/qims-23-1769","article-title":"Prognostic assessment of 18F-boronophenylalanine positron emission tomography (BPA-PET) in salvage boron neutron capture therapy for malignant brain tumors","volume":"14","author":"Lin","year":"2024","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0090","article-title":"Diagnostic accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in detecting high-grade gliomas: a systematic review and meta-analysis","volume":"13","author":"Castello","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13550-021-00865-9","article-title":"L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas","volume":"11","author":"Vettermann","year":"2021","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0100","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2967\/jnumed.110.086074","article-title":"Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer","volume":"52","author":"Okudaira","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000466688","article-title":"Serum amino acid profiles in normal subjects and in patients with or at risk of Alzheimer dementia","volume":"7","author":"Corso","year":"2017","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0110","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.apradiso.2011.02.037","article-title":"A micro-PET\/CT approach using O-(2-[18F]fluoroethyl)-L-tyrosine in an experimental animal model of F98 glioma for BNCT","volume":"69","author":"Menichetti","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0115","article-title":"First application of boron neutron capture therapy for recurrent clival chordoma with brainstem abutment","volume":"10","author":"Liao","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0120","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/RLU.0000000000006047","article-title":"Clinical utility of fluciclovine PET in BNCT for recurrent high-grade glioma","volume":"50","author":"Lan","year":"2025","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12149-019-01427-9","article-title":"Evaluation of the total distribution volume of 18F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling","volume":"34","author":"Romanov","year":"2020","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ucl.2018.03.015","article-title":"Imaging of prostate cancer using fluciclovine","volume":"45","author":"Savir-Baruch","year":"2018","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2026.02.239","article-title":"18F-fluciclovine for detection of recurrent brain metastases after radiation therapy: image interpretation criteria and diagnostic performance from the PURSUE study","author":"Kotecha","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00259-016-3487-1","article-title":"18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-Methionine PET","volume":"44","author":"Watabe","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109636_bb0145","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1007\/s00259-025-07668-3","article-title":"A LAT1-selective PET tracer, 5-[18F]F-alphaMe-3BPA, as a companion to its structurally matched 10B analog in boron neutron capture therapy","volume":"53","author":"Kondo","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:20:49Z","timestamp":1783041649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126000351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S0969805126000351"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109636","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative biological evaluation of [18F]fluciclovine, [18F]FBPA-Fr, and [18F]FET for boron neutron capture therapy: Preclinical validation and clinical feasibility","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109636"}}